acupuntura.com
LibraryAtlas
ExercisesNews
LibraryAtlas
ExercisesNews
acupuntura.com

Evidence-based medical acupuncture, physician-led at CEIMEC.

NAVIGATION

HomeArticlesConditionsAtlasMusclesExercises

CONTENT

NewsLibraryGuidesMultimodal

PATIENTS

SymptomsPain MapConditionsFAQFirst Session

INSTITUTIONAL

AboutTeamCEIMECWhy Trust Us

LEGAL

Editorial PolicyPrivacyTerms of UseLegal Notice

RESOURCE

Free Resource

No ads · No paywalls

01 · IDIOMA · LANGUAGE

Disponível em outras línguas

Disponible en otros idiomas

Available in other languages

Dr. Marcus Yu Bin Pai·Physician Acupuncturist

DISCLAIMER Information on acupuntura.com is educational and does not replace consultation with a qualified physician. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have.

acupuntura.com · 2025–2026Last reviewed: 2026-05-04
Back to News
Research
January 12, 2026
3 min reading time

Meta-Analysis of 52 Trials: Acupuncture Relieves Pain and Reduces Inflammation in Ankylosing Spondylitis

Systematic review with 2,600 patients shows that acupuncture reduces pain, morning stiffness, and inflammatory biomarkers — including IL-6, TNF-α, and CRP — as an adjunct to conventional treatment.

Source: Frontiers in Neurology(in English)DOI: 10.3389/fneur.2025.1652356
Meta-Analysis of 52 Trials: Acupuncture Relieves Pain and Reduces Inflammation in Ankylosing Spondylitis

Ankylosing spondylitis (AS) is a chronic inflammatory spondyloarthropathy that affects primarily the spine and sacroiliac joints, presenting with inflammatory low back pain, progressive morning stiffness, and risk of structural ankylosis. Although nonsteroidal anti-inflammatory drugs and biologic agents (TNF-α and IL-17 inhibitors) are pillars of treatment, many patients maintain residual symptoms or have intolerance or contraindications to biologic agents. A systematic review and meta-analysis published in Frontiers in Neurology compiled 52 randomized clinical trials with more than 2,600 patients to evaluate the effect of acupuncture as an adjunctive therapy, demonstrating significant reductions in both clinical symptoms and inflammatory biomarkers.

EFFECTS OF ACUPUNCTURE IN ANKYLOSING SPONDYLITIS

−1.26
MD — PAIN (VAS)
95% CI −1.44 to −1.09 — clinically relevant reduction
−3.49
MD — CRP (MG/L)
95% CI −4.12 to −2.85 — reduction in C-reactive protein
−5.36
MD — ESR (MM/H)
95% CI −6.82 to −3.89 — erythrocyte sedimentation rate
−1.32
MD — MORNING STIFFNESS (H)
95% CI −1.87 to −0.78 — duration reduction

Immunologic modulation: the differentiator of this analysis

The differentiator of this meta-analysis compared with previous reviews on acupuncture in AS is the systematic evaluation of immunologic markers. In addition to the usual clinical outcomes (pain, stiffness, BASDAI, and BASFI), Wang and colleagues analyzed inflammatory cytokines: interleukin-6 (IL-6), interleukin-17 (IL-17), tumor necrosis factor alpha (TNF-α), and immunoglobulin A (IgA). For all of these markers, the acupuncture-treated group showed significant reductions compared with control, suggesting that clinical effects are accompanied by modulation of the inflammatory immune profile characteristic of the disease.

FINDINGS ON DISEASE ACTIVITY INDICES

  • BASDAI (Bath AS Disease Activity Index): significant improvement in multiple studies
  • BASFI (Bath AS Functional Index): consistent functional improvement
  • IL-6: reduced — central cytokine in the inflammatory response of AS
  • IL-17: reduced — target of second-line biologics (secukinumab)
  • TNF-α: reduced — target of first-line biologic inhibitors
  • IgA: normalization — marker of intestinal and systemic activity

Proposed mechanism

The authors propose that acupuncture acts in AS through a neuro-immune-endocrine network. Stimulation of these acupoints has been associated with modulation of the HPA axis and parasympathetic innervation in experimental models, with possible reduction of pro-inflammatory cytokines. Points such as ST-36, SP-6, and GV-14 have shown immunomodulatory action in experimental models of inflammatory arthritis, which is compatible with the findings of this meta-analysis in patients with AS.

ROLE AS ADJUNCTIVE THERAPY

The included studies evaluated acupuncture as an adjunct to conventional treatment — not as a substitute for NSAIDs or biologics. This positioning is clinically appropriate: for the rheumatologist or medical acupuncturist, acupuncture may contribute additional control of pain and inflammatory modulation in patients who maintain residual symptoms despite optimized pharmacologic treatment, or who require dose reduction of medications because of adverse effects.

Substantial heterogeneity identified across studies — arising from variations in point protocols, number of sessions, and populations — imposes caution in interpretation. The authors highlight that 20 of the 52 RCTs were classified as having low risk of bias, which represents a reasonable basis for the general conclusions. Prospective trials with standardization of protocols and long-term follow-up are needed to define the positioning of acupuncture in management algorithms for ankylosing spondylitis.

Fonte Original

Frontiers in Neurology(em inglês)

Estudo Científico

DOI: 10.3389/fneur.2025.1652356
Content prepared by
CEIMEC — Centro de Estudo Integrado de Medicina Chinesa

Founded in 1989 by physicians trained at the University of São Paulo (USP) and specialized in China, CEIMEC is a Brazilian national reference in the teaching and practice of medical acupuncture. With more than 3,000 physicians trained over 35 years, it collaborates with HC-FMUSP and is recognized by the Brazilian Medical College of Acupuncture (CMBA/AMB).

Published on 2026-01-12

Learn More about this Topic

Related educational articles

Ankylosing Spondylitis: Assessment and Multimodal Treatment

Understand this chronic inflammatory disease of the spine — from early diagnosis to treatment with biologics.

Generalized Chronic Pain: Fibromyalgia and Sensitization

When pain is throughout the body — central mechanisms, fibromyalgia, sensitization syndrome, and a multimodal approach

All News